Zobrazeno 1 - 10 of 33 pro vyhledávání: '"Mette Pøhl"'
1
Akademický článek
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Autor: Erna-Elise Paulsen, Sigve Andersen, Mehrdad Rakaee, Mona Irene Pedersen, Ana Paola Lombardi, Mette Pøhl, Thomas Kilvaer, Lill-Tove Busund, Francesco Pezzella, Tom Donnem
Publikováno v: Frontiers in Oncology, Vol 13 (2023)
IntroductionNon-small cell lung carcinomas (NSCLC) exhibit different microvessel patterns (MVPs). Basal (BA), diffuse (DA) and papillary (PA) patterns show signs of angiogenesis (new blood vessels), while an alveolar pattern indicates that tumors are
Externí odkaz: https://doaj.org/article/5be10fff34704cc99defbb4c7f28bedd
Zobrazit plný text záznamu
2
Akademický článek
Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancer
Autor: Heidi Ryssel, Kristian Egebjerg, Susanne Dam Nielsen, Jens Lundgren, Mette Pøhl, Seppo W. Langer, Andreas Kjaer, Sisse Rye Ostrowski, Barbara Malene Fischer
Publikováno v: Frontiers in Immunology, Vol 13 (2022)
IntroductionThe immune system has proven to be a key player in the progression as well as containment of cancer with new treatment strategies based on immunotherapy targeting this interaction. Assessing immune function could reveal critical informati
Externí odkaz: https://doaj.org/article/aba1d9abb1da4ce1a4e5208fbd8c7f20
Zobrazit plný text záznamu
3
Impact of new cancer medicine – real-world evidence from Danish register study of lung cancer patients
Autor: Jan H. Rudolfsen, Mads D. Hjortsø, Mikkel H. Pedersen, Trine Pilgaard, Mette Pøhl
Publikováno v: Acta Oncologica. 62:253-260
Lung cancer (LC) is the leading cause of cancer deaths worldwide. Several new treatments have become available in recent decades, but little research exists on the impact of these on productivity, early retirement and survival for LC patients and the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03844cc7d8620b6725ea4c170825330e
https://doi.org/10.1080/0284186x.2023.2185104
Zobrazit plný text záznamu
5
Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups
Autor: Troels Bechmann, M.H. Nielsen, Tamás Lörincz, Marie Louise Holm Milo, Axel Cosmus Pyndt Diederichsen, Eva Holtved, Ebbe Laugaard Lorenzen, Marianne Nordsmark, Birgitte Vrou Offersen, Petra Witt Nyström, Tine Schytte, Christian Rønn Hansen, Mirjana Josipovic, Mette Pøhl, Maja V. Maraldo, E.S. Yates, Hanne Krogh Rose
Publikováno v: Milo, M L H, Offersen, B V, Bechmann, T, Diederichsen, A C P, Hansen, C R, Holtved, E, Josipovic, M, Lörincz, T, Maraldo, M V, Nielsen, M H, Nordsmark, M, Nyström, P W, Pøhl, M, Rose, H K, Schytte, T, Yates, E S & Lorenzen, E L 2020, ' Delineation of whole heart and substructures in thoracic radiation therapy : National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups ', Radiotherapy and Oncology, vol. 150, pp. 121-127 . https://doi.org/10.1016/j.radonc.2020.06.015
Background and purpose This study presents Danish consensus guidelines for delineation of the heart and cardiac substructures across relevant Danish Multidisciplinary Cancer Groups. Material and methods Consensus guidelines for the heart and cardiac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baa6db18b5e51029e5aece3055bcce78
https://doi.org/10.1016/j.radonc.2020.06.015
Zobrazit plný text záznamu
8
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study
Autor: Mette T. Mouritzen, Karen F. Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W. M. Nielsen, Anna Livbjerg, Jacob W. Larsen, Halla Skuladottir, Charlotte Kristiansen, Kim Wedervang, Tine Schytte, Karin H. Hansen, Anne-Cathrine Østby, Malene S. Frank, Jakob Lauritsen, Jens B. Sørensen, Seppo W. Langer, Gitte F. Persson, Jon L. Andersen, Pernille H. Homann, Emilie B. Kristensen, Lars B. Drivsholm, Martin Bøgsted, Heidi S. Christensen, Mette Pøhl, Birgitte Bjørnhart
Publikováno v: Mouritzen, M T, Junker, K F, Carus, A, Ladekarl, M, Meldgaard, P, Nielsen, A W M, Livbjerg, A, Larsen, J W, Skuladottir, H, Kristiansen, C, Wedervang, K, Schytte, T, Hansen, K H, Østby, A-C, Frank, M S, Lauritsen, J, Sørensen, J B, Langer, S W, Persson, G F, Andersen, J L, Homann, P H, Kristensen, E B, Drivsholm, L B, Bøgsted, M, Christensen, H S, Pøhl, M & Bjørnhart, B 2022, ' Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study ', Acta Oncologica, vol. 61, no. 4, pp. 409-416 . https://doi.org/10.1080/0284186X.2021.2023213
Mouritzen, M T, Junker, K F, Carus, A, Ladekarl, M, Meldgaard, P, Nielsen, A W M, Livbjerg, A, Larsen, J W, Skuladottir, H, Kristiansen, C, Wedervang, K, Schytte, T, Hansen, K H, Østby, A-C, Frank, M S, Lauritsen, J, Sørensen, J B, Langer, S W, Persson, G F, Andersen, J L, Homann, P H, Kristensen, E B, Drivsholm, L B, Bøgsted, M, Christensen, H S, Pøhl, M & Bjørnhart, B 2022, ' Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC : a Danish nationwide real-world study ', Acta Oncologica, vol. 61, no. 4, pp. 409-416 . https://doi.org/10.1080/0284186X.2021.2023213
Mouritzen, M T, Junker, K F, Carus, A, Ladekarl, M, Meldgaard, P, Nielsen, A W M, Livbjerg, A, Larsen, J W, Skuladottir, H, Kristiansen, C, Wedervang, K, Schytte, T, Hansen, K H, Østby, A C, Frank, M S, Lauritsen, J, Sørensen, J B, Langer, S W, Persson, G F, Andersen, J L, Homann, P H, Kristensen, E B, Drivsholm, L B, Bøgsted, M, Christensen, H S, Pøhl, M & Bjørnhart, B 2022, ' Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC : a Danish nationwide real-world study ', Acta Oncologica, vol. 61, no. 4, pp. 409-416 . https://doi.org/10.1080/0284186X.2021.2023213
Mouritzen, M T, Junker, K F, Carus, A, Ladekarl, M, Meldgaard, P, Nielsen, A W M, Livbjerg, A, Larsen, J W, Skuladottir, H, Kristiansen, C, Wedervang, K, Schytte, T, Hansen, K H, Østby, A-C, Frank, M S, Lauritsen, J, Sørensen, J B, Langer, S W, Persson, G F, Andersen, J L, Homann, P H, Kristensen, E B, Drivsholm, L B, Bøgsted, M, Christensen, H S, Pøhl, M & Bjørnhart, B 2022, ' Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC : a Danish nationwide real-world study ', Acta oncologica (Stockholm, Sweden), vol. 61, no. 4, pp. 409-416 . https://doi.org/10.1080/0284186X.2021.2023213
BACKGROUND: Immune checkpoint inhibitors (ICIs) are implemented as standard treatment for patients with advanced non-small cell lung cancer (NSCLC) in first-line and subsequent-line treatment. However, certain subgroups such as patients with older ag
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5a02ba76beaf13455a12c49ea8e04bb
https://vbn.aau.dk/da/publications/686eb154-1718-4f76-8653-85dceaffd10e
Zobrazit plný text záznamu
10
An investigative expansion of a competing risk model for first failure site in locally advanced non-small cell lung cancer
Autor: Gitte F. Persson, Thomas Lacoppidan, Malene Strange, Mette Pøhl, Lotte Nygård, Ivan R. Vogelius
Publikováno v: Acta Oncologica. 58:1386-1392
Introduction: We hypothesized that gross tumor volume (GTV) of primary tumor (GTVT) and nodal volumes (GTVN) were predictors of first failure site in non-small cell lung cancer (NSCLC). We aimed at...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::def4c98b580fb585be32457e1b08e37d
https://doi.org/10.1080/0284186x.2019.1631475
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje